Atorvastatin calcium plus amlodipine for the treatment of hypertension

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

(2012)   European Journal of Preventive Cardiology

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial

(2011) José Zamorano et al.   CURRENT MEDICAL RESEARCH AND OPINION

Atorvastatin: safety and tolerability

(2010) Vasilios G Athyros et al.   Expert Opinion On Drug Safety

A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors

(2010) F. Malekzadeh et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea

(2009) Danny Liew et al.   CLINICAL THERAPEUTICS

Pleiotropic Effects of Statins - Clinical Evidence

(2009) Vasilios Athyros et al.   CURRENT PHARMACEUTICAL DESIGN

International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme

(2009) Frederick D. Richard Hobbs et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update

(2009) Fabio Levi et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension

(2009) Kwang Kon Koh et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Use of a Single-Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo-Controlled, Multicenter Study

(2009) Joel M. Neutel et al.   Journal of Clinical Hypertension

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension

(2009) Peter S Sever et al.   JOURNAL OF HYPERTENSION

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial

(2009) John M. Flack et al.   MAYO CLINIC PROCEEDINGS

The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

(2009) Peter Lindgren et al.   PHARMACOECONOMICS

Coadministered Amlodipine and Atorvastatin Produces Early Improvements in Arterial Wall Compliance in Hypertensive Patients With Dyslipidemia

(2008) J. N. Cohn et al.   AMERICAN JOURNAL OF HYPERTENSION

Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

(2008) Chang-Jiang Ge et al.   HEART AND VESSELS

Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)

(2008) S Erdine et al.   JOURNAL OF HUMAN HYPERTENSION

Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis

(2008) José L. Martín-Ventura et al.   KIDNEY INTERNATIONAL

Prevención primaria farmacológica en hipertensión arterial y dislipemias

(2008) José R. González-Juanatey et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population

(2008) Ginés Sanz et al.   Nature clinical practice. Cardiovascular medicine

Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX)

(2007) François Charbonneau et al.   ATHEROSCLEROSIS